Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Central Nervous System Neoplasms 38Head and Neck Neoplasms 32Lung Neoplasms 31Squamous Cell Carcinoma of Head and Neck 28Lymphoma 27Carcinoma, Non-Small-Cell Lung 23Prostatic Neoplasms 21Breast Neoplasms 18Brain Neoplasms 18Leukemia 15Glioblastoma 15Sarcoma 13Gliosarcoma 13Uterine Cervical Neoplasms 12Astrocytoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Adenocarcinoma of Lung 11Burkitt Lymphoma 10Rhabdomyosarcoma 9Neoplasm Metastasis 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Rectal Neoplasms 8Radiation Injuries 8Oligodendroglioma 8Esophageal Neoplasms 8Colorectal Neoplasms 8Adenocarcinoma Of Esophagus 8Urinary Bladder Neoplasms 6Stomach Neoplasms 6

Interventions

Etoposide 2ibritumomab tiuxetan 1Vincristine 1Rituximab 1Radiotherapy 1Radioimmunotherapy 1Procarbazine 1Prednisone 1Methylprednisolone 1Lomustine 1Immunization, Passive 1Drug Therapy 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, AIDS-Related × Radiotherapy × Clear all
NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡